Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy

<div>Flowchart of the complete analysis procedure. DEmRNA, differentially expressed messenger RNA; CXC, compound Xueshuantong capsule; PDR, proliferative diabetic retinopathy; HXMMT, Hexuemingmu tablet; I-T, ingredient-target; PPI, protein-protein interaction; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; KEGG-T, Kyoto Encyclopedia of Genes and Genomes-target.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 

Figure 1 | Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 